The survival rate for cervical cancer in Australia

Posted in cervical cancer, prognosis; Posted 2 years ago by Andreas Obermair

Relative survival rates provide an estimation of what percentage of people with the same cancer are alive after the initial diagnosis of cancer, compared to healthy people of the same age and sex in the general population. To standardise across cancers, we normally report survival rates at five years.

Survival rates will not provide information about how long a patient may live (this would be virtually impossible to exactly predict), but can be used as an indicator of how successful the treatment is likely to be.

Five year survival rate

In 2013–2017, females diagnosed with all types and stages of cervical cancer combined had an overall 74% chance of surviving for five years compared to the general Australian population.

Cervical cancer has a higher likelihood of survival in comparison with the five-year survival rates for ovarian cancer (46%), although not as high as endometrial cancer (85%).

Survival rates are increasing slowly over time. Between 1988–1992 and 2013–2017, five-year relative survival for cervical cancer improved from 71% to 74%. You can see the most recent survival data is from 2013-2017 (over 5 years ago), so women diagnosed today may have a better survival outlook due to increasingly improved treatments.

For women diagnosed with early stage 1 disease the survival rate is much higher at about 92%.

Factors contributing to survival

Cervical cancer prognosis also depends on a range of factors, including

• Patient characteristics (age, lifestyle/smoking and other illnesses),
• The type of cervical cancer, and
• At what stage the cancer is diagnosed.

Those diagnosed with cervical cancer at an older age, patients who smoke, or patients with other medical life-threatening conditions typically have a poorer prognosis compared to those diagnosed at a younger age. However, sometimes young and otherwise perfectly healthy patients are diagnosed with vicious and very aggressive forms of cervical cancer.

Stages of cervical cancer

Stage 1 - The cancer is confined to the cervix, and has not spread beyond it. 

Stage 2 - The cancer has grown beyond the cervix and uterus, but has not spread to the walls of the pelvis or the lower part of the vagina. It has not spread to nearby lymph nodes.

Stage 3 - The cancer has spread to the lower part of the vagina or the walls of the pelvis. The cancer may be blocking the ureters (tubes that carry urine from the kidneys to the bladder). It may have spread to nearby lymph nodes.

Stage 4 - The cancer has grown into the bladder or rectum, or to other organs like the lungs or bones.

You can read more about cervical cancer stages here.

Cervical cancer treatment

In brief, patients with early cervical cancer (stage 1) would benefit from surgical treatment, whereas patients with stage 2 to 4 would not benefit from surgical treatment.

Survival rates for cervical cancer have improved over time due to more accurate screening, diagnosis and staging of disease, improvements in the speed of referral, availability of evidence-based guidelines, and advances in surgery.

Read more about cervical cancer treatment here.

Can cervical cancer return?

It is possible for cancer of all types and stages to recur. In patients with stage 1 cervical cancer, recurrence may be local or in the pelvis or at distant sites, such as the abdomen or lungs. In patients with stage 2 to 4 cervical cancer, the cancer can persist (despite treatment) or recur after successful initial treatment after some time.

After five years from diagnosis and treatment, the risk of a recurrence becomes low. Patients need to be aware of the signs of recurrence.

Survival rates are a guide only and you may have worries or questions. A gynaecological oncologist can discuss how these estimates apply to you. If this is something you wish to discuss, please arrange an appointment.

If you wish to receive regular information, resources, reassurance and inspiration for up-to-date care that is sound and in line with the latest research, please subscribe to my blog via the form above, or like Dr Andreas Obermair on Facebook.